Robert Cook
Professor/M.D. | University of Florida
Gainesville, FL, UNITED STATES
Dr. Robert Cook is a professor within the Department of Epidemiology focusing on preventative health care.
Biography
Dr. Robert Cook is a professor within the Department of Epidemiology focusing on preventative health care, and he also serves as a physician at UF Health Internal Medicine – Medical Plaza.
Areas of Expertise (7)
Primary Care Medicine
Alcohol Consumption
Sexually Transmitted Diseases
HIV Infection
Stigma
Medical Marijuana
Infectious Disease Epidemiology
Articles (3)
Age-Associated Gut Dysbiosis, Marked by Loss of Butyrogenic Potential, Correlates With Altered Plasma Tryptophan Metabolites in Older People Living With HIV
Journal of Acquired Immune Deficiency SyndromeSmita Ghare, et al.
2022-02-01
Imbalance in tryptophan (TRP) metabolism and its neuroactive metabolites, serotonin and kynurenine (KYN), is a known pathogenic mechanism underlying neurocognitive impairment. Gut microbiota plays an important role in TRP metabolism, and the production of these neuroactive molecules affects neurocognitive function.
Association of Therapeutic and Recreational Reasons for Alcohol Use With Alcohol Demand
Experimental and Clinical PsychoparmacologyE. Ferguson, et al.
2022-01-01
Motives for alcohol use and behavioral economic measures of demand are associated with alcohol consumption and alcohol-related problems. However, it is unclear how differences in reasons for alcohol use may affect alcohol demand. Additionally, although alcohol is commonly used to self-manage conditions such as pain and sleep problems, the impact of these reasons for alcohol use on alcohol demand is not well characterized.
Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV
AIDS and BehaviorKathleen A. McGinnis, et al.
2021-09-20
The timeline followback (TLFB) takes more resources to collect than the Alcohol Use Disorder Identification Test (AUDIT-C). We assessed agreement of TLFB and AUDIT-C with the biomarker phosphatidylethanol (PEth) and compared changes in TLFB and PEth among persons with HIV (PWH) using secondary data from randomized trials. We calculated operating characteristics and agreement between TLFB (> 1 and > 2 average drinks/day), AUDIT-C ≥ 4 and PEth ≥ 20 among 275 men with HIV.
